https://ankyratx.com/press-releases/ankyra-therapeutics-announces-trial-in-progress-poster-presentation-at-2024-asco-meeting-and-approval-of-ank-101-phase-1-protocol-amendment/
Ankyra Therapeutics will provide an update on the status of the ANK-101 Phase 1 ANCHOR clinical trial at ASCO 2024 and has received approval by FDA and Health...
in progressposter presentationankyratherapeuticsannounces